TRILLIUM THERAPEUTICS INC's ticker is and the CUSIP is 89620X506. A total of 29 filers reported holding TRILLIUM THERAPEUTICS INC in Q4 2016. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $790,000 | +199.2% | 45,000 | -25.0% | 0.06% | +255.6% |
| Q2 2017 | $264,000 | +187.0% | 60,013 | +269.6% | 0.02% | +100.0% |
| Q4 2016 | $92,000 | -29.8% | 16,239 | +11.1% | 0.01% | -47.1% |
| Q2 2016 | $131,000 | -26.4% | 14,614 | -26.1% | 0.02% | -59.5% |
| Q4 2014 | $178,000 | – | 19,783 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VR Adviser, LLC | 4,040,000 | $59,428,000 | 8.74% |
| Fairmount Funds Management LLC | 1,478,181 | $21,744,000 | 7.78% |
| COMMODORE CAPITAL LP | 852,871 | $12,546,000 | 6.82% |
| Ghost Tree Capital, LLC | 1,950,000 | $28,685,000 | 6.39% |
| Endurant Capital Management LP | 655,741 | $9,646,000 | 3.48% |
| FRAZIER MANAGEMENT LLC | 3,053,107 | $44,879,000 | 3.46% |
| ACUTA CAPITAL PARTNERS, LLC | 803,000 | $11,812,000 | 3.21% |
| NEA Management Company, LLC | 5,736,363 | $84,382,000 | 2.23% |
| Tri Locum Partners LP | 296,838 | $4,366,000 | 1.59% |
| Avidity Partners Management LP | 3,185,200 | $46,854,000 | 1.52% |